Sarah Ford
New York Times Puts the Spotlight on Progress in Marfan Research
In the 1970s, the life expectancy for someone with Marfan syndrome was in the 40s. Less than thirty years later, due to early diagnosis, new medications, and advances in surgery, the life expectancy for people with Marfan syndrome was in the 70s, nearing the life expectancy of the general population.
In the past decade, research has accelerated even faster, giving our community real hope for a medication that may prevent aortic enlargement, the life-threatening part of Marfan syndrome, and a potential blood test that could predict who is at risk for aortic problems. The December 3 issue of the New York Times put the focus on these recent research breakthroughs that offer our community hope.
Source: The Marfan Foundation
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Corporate Volunteering: The Business Case for an Employee Volunteer Program
Corporate volunteering has evolved well beyond the occasional company service day. A well-designed employee volunteer program can strengthen employee engagement, reinforce company culture, develop leadership skills,…
Environmental Awareness Month
Every September, environmental organizations around the Nation come together in recognition of Environmental Awareness Month, with a goal to raise awareness about environmental issues that…
Join Feeding America and Take Action During Hunger Action Month
No one should have to go hungry in the richest country in the world — yet millions of Americans don’t have enough to eat. Our…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
